The Newsroom    Published Thursday, Nov. 9, 2006, 12:51 PM
Print   |   
« Back   |   

Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation

New England Journal of Medicine, Nov. 9, 2006http://content.nejm.org/cgi/content/short/355/19/1967 The published research relates to treatment methodologies following renal transplant.  One principal investigator, who is part of the Thymoglobulin Induction Study Group, is UTMB’s Kristene Gugliuzza. Others are Saint Barnabas Medical Center, L. Bonomini; Washington University and Barnes, Jewish Hospital, D.C. Brennan; Westchester Medical Center, K.M.H. Butt; University of Michigan Hospital, D. Cibrik; University of Alabama at Birmingham, R. Gaston; Emory University Hospital, C. Gausch.



Follow Us:
The Newsroom is a service provided by the Office of Public Affairs  •  Questions or Comments?